
Reset all filters
01 1American Massage Therapy Association
02 1Bayer AG
03 8Covis Pharma
04 2Hanlim Pharmaceuticals Inc
05 7Viatris
Reset all filters
01 1Nisoldipine 10Mg 24 Units Of Oral Use
02 2TABLET
03 16TABLET, EXTENDED RELEASE;ORAL
Reset all filters
01 6DISCN
02 2Generic
03 10RX
04 1Blank
Reset all filters
01 2NISOLDIN
02 8NISOLDIPINE
03 8SULAR
04 1Syor
Reset all filters
01 1Italy
02 2South Korea
03 16USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2023-04-10
Application Number : 216606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Syor
Dosage Form : Nisoldipine 10Mg 24 Units Of Oral Use
Dosage Strength : 24 cpr riv 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 34MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 17MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NISOLDIN
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging : 60T, 300T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NISOLDIN
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging : 60T, 300T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 17MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25.5MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 34MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA